Larimar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Larimar Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $-0.24 | $-0.37 | 35.1 % |
Jun 2024 | 2024-08-07 | $-0.34 | $-0.30 | -13.3 % |
Mar 2024 | 2024-05-09 | $-0.27 | $-0.24 | -12.5 % |
Dec 2023 | 2024-03-14 | $-0.30 | $-0.25 | -20.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Larimar Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3.
Larimar Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3 and the Actual EPS was $-0.24, which beat the estimate of $-0.37.
Larimar Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 30, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.